Fortis Healthcare

649.55
-4.45
(-0.68%)
Market Cap
49,038.31 Cr
EPS
7.93
PE Ratio
62.57
Dividend Yield
0.15 %
52 Week High
744.50
52 Week Low
406.00
PB Ratio
6.29
Debt to Equity
0.14
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from13 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+92.31 %
+92.31 %
Hold
Hold0.0 %
0.0 %
Sell
Sell+7.69 %
+7.69 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,089.30
#1 1,05,895.43
103.08
5,584.10
18.77
#1 1,058
-17.46
51.00
6,780.95
97,499.66
74.99
#1 19,165.50
14.74
917
49.14
62.56
649.55
#3 49,038.31
#4 62.57
#2 6,931.20
#10 8.99
#4 645
#1 89.49
51.60
1,699.95
34,740.31
44.06
5,093.40
10.96
790
2.66
63.10
1,269.95
34,109.25
65.05
2,759.20
#1 25.09
326
15.71
59.10
500.30
24,990.64
93.82
3,723.70
22.85
205
-69.22
72.68
616.75
24,678.57
68.22
2,511.20
12.94
336
20.76
56.67
1,530.85
15,546.04
63.54
1,334.00
10.76
218
10.06
74.19
5,500.00
12,539.44
#1 28.46
599.90
11.69
58
8.85
51.81
1,450.55
9,510.68
48.56
1,095.50
21.32
177
20.14
39.35
Growth Rate
Revenue Growth
8.99 %
Net Income Growth
1.93 %
Cash Flow Change
33.79 %
ROE
-3.46 %
ROCE
14.14 %
EBITDA Margin (Avg.)
3.01 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
1,085
1,152
1,150
1,024
1,106
1,176
1,257
1,630
1,164
1,229
1,258
1,175
1,108
1,081
1,156
1,164
1,528
1,170
1,277
1,178
1,133
614
1,029
1,205
1,278
1,733
1,475
1,487
1,391
1,519
1,682
1,586
1,669
1,667
1,788
1,699
1,803
1,873
2,006
1,975
Expenses
1,022
986
1,087
1,066
1,091
1,059
1,097
1,023
1,045
1,071
1,138
1,069
1,907
1,034
1,172
1,193
1,069
996
1,028
1,012
987
709
875
987
1,055
1,135
1,178
1,180
1,157
1,237
1,304
1,283
1,372
1,386
1,440
1,396
1,405
1,516
1,613
1,553
EBITDA
62
166
62
-42
15
118
160
607
118
158
120
106
-799
47
-16
-29
459
174
250
166
146
-96
155
218
223
598
297
307
234
282
378
302
297
282
349
303
398
356
393
422
Operating Profit %
3 %
4 %
-2 %
-5 %
-2 %
6 %
8 %
10 %
7 %
7 %
5 %
5 %
-76 %
1 %
-3 %
-8 %
10 %
13 %
15 %
13 %
11 %
-17 %
12 %
16 %
16 %
20 %
19 %
20 %
16 %
17 %
19 %
18 %
16 %
16 %
19 %
17 %
21 %
18 %
19 %
19 %
Depreciation
61
53
0
0
72
48
52
60
63
59
61
59
60
57
56
60
60
71
71
70
80
72
74
73
72
73
75
76
77
74
77
83
82
79
84
87
92
91
95
97
Interest
37
34
30
32
38
42
46
75
67
64
66
63
64
76
85
111
65
51
49
48
57
41
42
42
41
38
40
38
30
31
33
33
32
32
32
33
35
35
36
45
Profit Before Tax
-22
88
44
-58
-96
28
62
472
-11
35
-7
-17
-924
-87
-157
-201
334
52
130
48
9
-208
38
103
110
486
182
193
126
176
268
186
183
171
233
183
271
230
261
279
Tax
-10
-9
-17
-29
-8
3
24
19
26
12
17
3
-9
-34
-15
-20
183
-26
6
118
50
-20
23
49
48
56
51
51
39
42
50
44
45
47
49
49
68
56
68
25
Net Profit
-12
97
61
-29
-88
25
38
453
-38
23
-24
-19
-914
-53
-142
-180
151
78
124
-69
-41
-188
16
54
62
431
131
142
87
134
218
142
138
124
184
134
203
174
193
254
EPS in ₹
-0.38
2.01
1.19
-0.65
-1.91
0.35
0.68
9.49
-0.79
0.10
-0.88
-0.71
-17.97
-1.36
-3.21
-3.06
1.80
0.90
1.47
-1.01
-0.59
-2.37
-0.05
0.40
0.57
3.49
1.42
1.55
0.90
1.62
2.71
1.72
1.76
1.48
2.30
1.78
2.37
2.20
2.34
3.28

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
7,616
7,232
9,717
8,622
11,951
11,348
11,155
11,885
12,434
13,289
Fixed Assets
4,218
3,776
5,419
4,992
8,477
8,802
8,799
9,416
9,426
9,874
Current Assets
1,636
1,434
1,775
1,282
1,667
941
1,037
1,133
1,406
1,421
Capital Work in Progress
228
201
268
226
450
204
165
194
228
542
Investments
616
1,449
1,878
1,732
270
175
186
104
210
230
Other Assets
2,554
1,807
2,152
1,672
2,755
2,167
2,005
2,172
2,569
2,643
Total Liabilities
7,616
7,232
9,717
8,622
11,951
11,348
11,155
11,885
12,434
13,289
Current Liabilities
1,602
1,476
1,927
2,134
3,591
2,579
1,233
1,269
1,426
3,170
Non Current Liabilities
1,813
1,616
1,480
1,171
1,248
1,563
3,204
3,607
2,907
1,563
Total Equity
4,201
4,140
6,311
5,317
7,113
7,206
6,718
7,008
8,100
8,556
Reserve & Surplus
3,585
3,534
4,626
3,543
5,846
5,906
5,365
5,423
6,487
6,908
Share Capital
463
463
518
519
755
755
755
755
755
755

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-66
-38
225
-513
799
-627
212
-153
-22
125
Investing Activities
213
122
-1,001
-333
-3,279
64
-131
-501
-373
-889
Operating Activities
24
195
967
493
-179
172
486
865
822
1,100
Financing Activities
-304
-354
259
-672
4,257
-862
-143
-517
-471
-87

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
26.32 %
0.00 %
23.24 %
23.31 %
25.26 %
26.77 %
DIIs
13.44 %
15.20 %
15.66 %
15.50 %
16.72 %
17.44 %
19.94 %
20.38 %
20.70 %
22.16 %
26.55 %
29.35 %
31.15 %
32.31 %
30.73 %
30.05 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.96 %
15.16 %
15.98 %
14.89 %
13.96 %
13.58 %
12.92 %
12.39 %
12.05 %
11.80 %
11.13 %
11.04 %
10.82 %
10.47 %
10.36 %
10.21 %
Others
41.43 %
38.47 %
37.20 %
38.44 %
38.15 %
37.82 %
35.98 %
36.06 %
36.08 %
34.86 %
4.83 %
28.44 %
3.63 %
2.75 %
2.48 %
1.81 %
No of Share Holders
0
1,09,889
1,44,634
1,66,743
1,54,572
1,56,881
1,60,762
1,58,455
1,37,894
1,35,047
1,31,516
1,35,664
1,57,165
1,54,260
2,04,184
2,21,750

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1 1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.24 0.14 0.00

Corporate Action

Announcements

Compliances-Half Yearly Report (SEBI Circular No. CIR/IMD/DF-1/67/2017) 4 days ago
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Apr 03, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Apr 03, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 02, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 02, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) - Regarding Fortis Trademarks And Allied Trademarks.Apr 02, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) - Regarding Fortis Trademarks And Allied Trademarks.Apr 02, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 21, 2025
Update On Acquisition Announcement Dated February 14 2025Mar 21, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 20, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 20, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015.Mar 20, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 19, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 18, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2025
Acquisition Of Shrimann Superspecialty Hospital.Feb 14, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 14, 2025
Announcement under Regulation 30 (LODR)-AcquisitionFeb 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 08, 2025
Statement Of Deviation And Variation.Feb 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 07, 2025
Compliances-Reg. 54 - Asset Cover details Feb 07, 2025
Integrated Filing (Financial)Feb 07, 2025
Updated Policy Of Materiality Of EventsFeb 07, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationFeb 07, 2025
Outcome Of The Board Meeting Under Regulation 30 And Regulation 51(2) And 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015Feb 07, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 And Regulation 51(2) And 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) RegulatFeb 07, 2025
Reschedule Of Investor/Analysts MeetFeb 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 07, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015.Feb 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 29, 2025
Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 29, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJan 17, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJan 16, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Jan 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 15, 2025
Announcement Under Regulation 30 Of SEBI (LODR) - Change In DesignationDec 27, 2024
Appointment Of Chairman.Dec 27, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 27, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateDec 27, 2024
Board Meeting Outcome for Outcome Of The Board Meeting-December 27 2024Dec 27, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 13, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 09, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 09, 2024

Technical Indicators

RSI(14)
Neutral
51.60
ATR(14)
Volatile
29.30
STOCH(9,6)
Neutral
36.25
STOCH RSI(14)
Neutral
25.32
MACD(12,26)
Bearish
-0.97
ADX(14)
Weak Trend
18.97
UO(9)
Bearish
50.61
ROC(12)
Downtrend And Accelerating
-0.56
WillR(14)
Neutral
-58.38

About Fortis Healthcare

Fortis Healthcare Limited is one of India's largest healthcare providers, operating 27 hospitals with 4,500 operational beds and over 426 diagnostics centres as of March 31, 2023. The company offers a wide range of integrated healthcare services including cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology, and mother and child care. Fortis uses advanced technology to deliver quality healthcare in modern facilities. Its subsidiary, SRL Limited, is a leading diagnostics chain in India. Fortis Healthcare has a presence in India, Dubai, Mauritius, and Sri Lanka. The company has expanded through acquisitions and new facility launches over the years, focusing on its core Indian market in recent times. It provides inpatient and outpatient services, sells medical and non-medical items, and offers management services to hospitals. Fortis Healthcare's specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, urology, neurosurgery, radiology, orthopedics, and organ transplant.
Listing Date
09 May, 2007(17 Years, 37 days)
Chairperson NameLeo Puri